Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

USANA HEALTH SCIENCES, INC. (USNA)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

USANA Health Sciences, Inc. : USANA Schedules First Quarter Earnings Release and Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:50pm CET

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market Tuesday, April 24, 2012. USANA executives will hold a conference call to discuss this announcement with analysts and institutional investors the following morning at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.

The webcast is also being distributed over Thomson's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson's Individual Investor Network. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

About USANA

USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France and Belgium. Additionally, USANA's wholly owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.

USANA Health Sciences, Inc.
Patrique Richards, 801-954-7961
Investor Relations
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on USANA HEALTH SCIENCES, INC
02/15USANA HEALTH SCIENCES : Reports Record Fourth Quarter and Full-Year 2017 Net Sal..
AQ
02/07USANA HEALTH SCIENCES : reports 4Q loss
AQ
02/06USANA HEALTH SCIENCES INC : Results of Operations and Financial Condition, Regul..
AQ
02/06USANA HEALTH SCIENCES : Reports Record Fourth Quarter and Full-Year 2017 Net Sal..
BU
02/05USANA HEALTH SCIENCES : Unleash Your Body's Age-Defying Power With Revolutionary..
PR
01/11USANA : Lands Deal With USA Nordic; Becomes Official Supplement Supplier Of Wint..
PR
01/10USANA HEALTH SCIENCES : Schedules Fourth Quarter Earnings Release and Conference..
BU
01/08USANA HEALTH SCIENCES INC : Regulation FD Disclosure, Financial Statements and E..
AQ
01/08USANA HEALTH SCIENCES : Provides Estimated Impact of U.S. Tax Reform
BU
2017USANA HEALTH SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
More news
News from SeekingAlpha
02/20DAILY INSIDER RATINGS ROUND UP 2/16/ : Mli, odt, rarx, snap, ston, wair 
02/19BY THE NUMBERS : Cheap Stocks With Solid Fundamentals 
02/07USANA Health Sciences' (USNA) Q4 2017 Results - Earnings Call Transcript 
02/06USANA Q4 sales down 7%; non-GAAP earnings down 19% 
02/06USANA Health Sciences beats by $0.11, beats on revenue 
Financials ($)
Sales 2018 1 118 M
EBIT 2018 152 M
Net income 2018 104 M
Finance 2018 283 M
Yield 2018 -
P/E ratio 2018 16,91
P/E ratio 2019 15,22
EV / Sales 2018 1,38x
EV / Sales 2019 1,24x
Capitalization 1 826 M
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Technical analysis trends USANA HEALTH SCIENCES, INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 87,3 $
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Kevin G. Guest Chief Executive Officer & Director
Jim Brown President & Chief Operating Officer
Myron W. Wentz Chairman
G. Douglas Hekking Chief Financial Officer
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES, INC.3.51%1 826
PROCTER & GAMBLE COMPANY-12.02%202 285
UNILEVER (NL)-7.39%155 439
UNILEVER-8.85%155 439
COLGATE-PALMOLIVE COMPANY-8.03%60 520
RECKITT BENCKISER-14.44%57 684